News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
38,714 Results
Type
Article (2505)
Company Profile (44)
Press Release (36165)
Section
Business (14334)
Career Advice (87)
Deals (2108)
Drug Delivery (8)
Drug Development (4221)
Employer Resources (11)
FDA (456)
Job Trends (799)
News (20729)
Policy (1464)
Tag
Academia (156)
Alliances (3500)
Alzheimer's disease (66)
Antibody-drug conjugate (ADC) (7)
Approvals (457)
Bankruptcy (10)
Best Places to Work (513)
Biosimilars (9)
Biotechnology (33)
Breast cancer (13)
Cancer (88)
Career advice (74)
CAR-T (8)
Cell therapy (25)
Clinical research (3174)
Collaboration (51)
Compensation (27)
COVID-19 (212)
C-suite (16)
Data (67)
Diagnostics (472)
Earnings (4232)
Employer resources (9)
Events (6006)
Executive appointments (45)
FDA (483)
Funding (47)
Gene editing (10)
Gene therapy (8)
GLP-1 (55)
Government (312)
Healthcare (769)
Infectious disease (214)
Inflammatory bowel disease (10)
Intellectual property (9)
Interviews (9)
IPO (995)
Job creations (293)
Job search strategy (72)
Layoffs (34)
Legal (242)
Lung cancer (11)
Manufacturing (13)
Medical device (329)
Medtech (329)
Mergers & acquisitions (1144)
Metabolic disorders (19)
Neurodegenerative disease (9)
Neuroscience (96)
NextGen Class of 2024 (370)
Non-profit (174)
Northern California (234)
Opinion (15)
Patents (14)
People (5613)
Phase I (1346)
Phase II (1590)
Phase III (859)
Pipeline (33)
Postmarket research (38)
Preclinical (581)
Radiopharmaceuticals (11)
Rare diseases (11)
Real estate (421)
Regulatory (998)
Research institute (150)
Resumes & cover letters (9)
Schizophrenia (9)
Series A (10)
Southern California (225)
Startups (487)
United States (1114)
Vaccines (23)
Date
Last 7 days (47)
Last 30 days (174)
Last 365 days (2674)
2024 (2606)
2023 (2943)
2022 (3837)
2021 (4253)
2020 (3657)
2019 (2211)
2018 (1651)
2017 (1833)
2016 (1678)
2015 (1881)
2014 (1418)
2013 (1216)
2012 (1450)
2011 (1380)
2010 (1209)
Location
Africa (49)
Arizona (15)
Asia (1916)
Australia (335)
California (520)
Canada (97)
China (23)
Colorado (11)
Connecticut (9)
Europe (3923)
Florida (29)
Illinois (12)
Indiana (21)
Kansas (12)
Maryland (19)
Massachusetts (186)
Minnesota (13)
New Jersey (35)
New York (33)
North Carolina (74)
Northern California (234)
Ohio (20)
Pennsylvania (22)
South America (48)
Southern California (225)
Texas (40)
Washington State (30)
38,714 Results for "vigilant biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Lone Star Bio
Gradalis Highlights Importance of Clonal Neoantigen Targeting for Clinical Benefit of Vigil® in Oncology Reviews Publication
Gradalis, Inc. announced the peer-reviewed publication in Oncology Reviews, a Frontiers Open Access Journal, highlighting Vigil activity in ovarian cancer related to clonal neoantigen expression and the HRP molecular profile.
September 28, 2023
·
7 min read
Lone Star Bio
Gradalis to Host Virtual KOL Discussion on the Vigil® Platform Entering Phase 2 for Platinum-Sensitive Recurrent Ovarian Cancer on October 25, 2023
Gradalis, Inc. announced that it will host a virtual KOL discussion on the Vigil® platform entering Phase 2 for platinum-sensitive recurrent ovarian cancer on Wednesday, October 25, 2023 at 11:00am ET.
October 18, 2023
·
7 min read
Press Releases
HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
November 21, 2024
·
1 min read
Press Releases
HARMONY BIOSCIENCES TO PARTICIPATE IN OPPENHEIMER MOVERS IN RARE DISEASE SUMMIT
December 4, 2024
·
1 min read
Layoffs
Aadi Bioscience to Lay Off 80% of R&D Staff
Aadi Bioscience expects that pipeline adjustments and the workforce reduction will extend its cash runway into at least the second half of 2026.
August 21, 2024
·
1 min read
·
Angela Gabriel
Press Releases
INVO Bioscience and NAYA Biosciences Close Merger, Combined Company to Operate as NAYA Biosciences (NASDAQ: NAYA)
October 15, 2024
·
5 min read
Press Releases
LIfT BioSciences expands into Ireland for manufacturing & clinical operations
November 18, 2024
·
5 min read
Press Releases
Solid Biosciences to Present at the Jefferies London Healthcare Conference
November 14, 2024
·
1 min read
Press Releases
Rigaku BioScience Lab Opens in USA
November 21, 2024
·
3 min read
Press Releases
Neurocrine Biosciences to Participate at Investor Conferences in December
November 26, 2024
·
2 min read
1 of 3,872
Next
